A Fighter for Fair Competition
Dean M. Harvey fights on behalf of workers, consumers, and small businesses in antitrust and intellectual property cases.
Dean is among the nation’s leading advocates for workers asserting antitrust claims. He represented a nationwide class of over 64,000 high-tech workers against Google, Apple, Intel and other tech giants for conspiring to suppress the mobility and compensation of their technical employees. This landmark case resulted in the largest recovery (by far) of any class action asserting antitrust claims in the employment context: $435 million. The Daily Journal described the case as the “most significant antitrust employment case in recent history,” adding that it “has been widely recognized as a legal and public policy breakthrough.” The case is the subject of an upcoming documentary film, When Rules Don’t Apply.
Dean continues the fight to ensure that employees receive competitive compensation. He represents a certified class of over 5,000 academic doctors at Duke and UNC regarding an understanding between the schools not to compete for each other’s faculty. The case is set for trial in July of 2019. He is co-lead interim class counsel of a proposed nationwide class of workers alleging a conspiracy between the world’s two leading rail equipment suppliers to suppress the pay of their employees. He is also proposed co-lead class counsel in several cases against the nation’s leading fast food franchisors, challenging franchise agreements that prohibited franchisees from competing for each other’s workers.
Dean also represents consumers and small businesses in cases challenging price-fixing conspiracies, particularly regarding the exorbitant prices of prescription drugs. For example, the Cipro litigation led to a landmark (and unanimous) decision by the California Supreme Court upholding the rights of consumers to challenge backroom deals between brand name drug makers and generic manufacturers to eliminate competition for life-saving medications. That case let to total settlements of $399 million, nearly $68 million more than estimated damages. The trial court described the outcome as “extraordinary,” adding that it was “not aware of any case” that “has taken roughly 17 years,” where, net of fees, end-payor “claimants will get basically 100 cents on the dollar[.]”
Dean also represents a municipal public employee union and other proposed class members challenging a wide-ranging alleged conspiracy among generic drug makers to inflate the prices of many generic drugs. The conspiracy has been described as most likely the largest cartel in the history of the United States.
Dean previously worked for the Antitrust Division of the United States Department of Justice, and was a Law Clerk to the Honorable James V. Selna of the United States District Court for the Central District of California.
In 2017, the American Bar Association recognized Dean as one of the top 40 young lawyers in the country, and the Daily Journal included Dean in its “Top 40 Under 40” list of the most esteemed California attorneys under the age of 40. In 2016, Dean received a California Lawyer Attorneys of the Year (CLAY) award for the Cipro antitrust litigation. From 2013 to the present, Super Lawyers has named Dean a “Super Lawyer,” after naming him a “Rising Star” from 2010 through 2012. In 2013, The Recorder recognized Dean as a “Lawyer on the Fast Track,” one of 50 attorneys in California “whose early accomplishments indicate they will be tomorrow’s top lawyers and leaders.” In 2006, Dean received the first annual William E. Swope Antitrust Writing Award for his paper, “Anticompetitive Social Norms as Antitrust Violations,” published by the California Law Review.
Dean is Co-Chair of the American Bar Association Section of Antitrust Law, Competition Torts Committee, is a member of the American Antitrust Institute’s Advisory Board, and has served as a member of the Law360 Competition Editorial Advisory Board.